3.90
price down icon2.74%   -0.11
after-market アフターアワーズ: 3.90
loading
前日終値:
$4.01
開ける:
$4.05
24時間の取引高:
373.90K
Relative Volume:
3.13
時価総額:
$449.54M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-14.10%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$3.80
$4.08
1週間の範囲:
Value
$3.80
$4.71
52週間の値動き範囲:
Value
$3.80
$5.14

Novabridge Biosciences Adr Stock (NBP) Company Profile

Name
名前
Novabridge Biosciences Adr
Name
セクター
Healthcare (1134)
Name
電話
-
Name
住所
-
Name
職員
32
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
NBP's Discussions on Twitter

NBP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
NBP
Novabridge Biosciences Adr
3.90 462.22M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.82 107.58B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.32 80.03B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
429.80 57.37B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
917.93 55.83B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
209.02 44.13B 447.02M -1.18B -906.14M -6.1812

Novabridge Biosciences Adr Stock (NBP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-03 開始されました Leerink Partners Outperform
2025-09-09 開始されました BTIG Research Buy
2021-12-09 開始されました Siebert Williams Shank Buy
2021-06-02 開始されました Daiwa Securities Buy
2021-03-15 開始されました Needham Buy
2021-03-03 繰り返されました H.C. Wainwright Buy
2021-02-25 開始されました Piper Sandler Overweight
2020-12-07 開始されました H.C. Wainwright Buy
2020-07-27 開始されました Cantor Fitzgerald Overweight
2020-02-12 開始されました China Renaissance Buy
2020-02-11 開始されました Jefferies Buy
すべてを表示

Novabridge Biosciences Adr (NBP) 最新ニュース

pulisher
Nov 21, 2025

NovaBridge subsidiary Visara appoints two key ophthalmology leaders By Investing.com - Investing.com Nigeria

Nov 21, 2025
pulisher
Nov 20, 2025

NovaBridge subsidiary Visara appoints two key ophthalmology leaders - Investing.com India

Nov 20, 2025
pulisher
Nov 20, 2025

NovaBridge’s Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward - GlobeNewswire Inc.

Nov 20, 2025
pulisher
Nov 18, 2025

How does Talphera Inc (TLPH) change from a tortoise to a hare? - Setenews

Nov 18, 2025
pulisher
Nov 03, 2025

This trade activity should not be overlooked: Zooz Strategy Ltd (ZOOZ) - setenews.com

Nov 03, 2025
pulisher
Nov 03, 2025

There is no way NovaBridge Biosciences. ADR (NBP) can keep these numbers up - setenews.com

Nov 03, 2025
pulisher
Nov 03, 2025

Prepare Yourself for Liftoff: Sandisk Corp (SNDK) - Setenews

Nov 03, 2025
pulisher
Nov 02, 2025

NBP Financial Statements & ChartsNovabridge Biosciences.Adr MacroTrends - CMLviz

Nov 02, 2025
pulisher
Nov 02, 2025

NBP Interactive Stock ChartNovabridge Biosciences.Adr. Stock Analysis - CMLviz

Nov 02, 2025
pulisher
Nov 02, 2025

NBP Pivot Points, Technical Analysis and Moving AveragesNovabridge Biosciences.Adr Technicals - CMLviz

Nov 02, 2025
pulisher
Oct 31, 2025

Total equity of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Equity in earnings of NovaBridge Biosciences Sponsored ADR – NASDAQ:NBP - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

symbol__ Stock Quote Price and Forecast - CNN

Oct 31, 2025
pulisher
Oct 31, 2025

NBP Forecast — Price Target — Prediction for 2026 - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

NBP Stock Price and Chart — NASDAQ:NBP - TradingView

Oct 31, 2025
pulisher
Oct 30, 2025

NBPNovaBridge Biosciences. ADR Stock Price and Quote - Finviz

Oct 30, 2025
pulisher
Oct 29, 2025

I-MAB (Nasdaq: IMAB) Transitions to NovaBridge Biosciences (Nasdaq: NBP) with Trading Effective October 30, 2025 New Brand and Logo to Reflect Strategic Transformation to a Global Biotech Platform - Barchart.com

Oct 29, 2025
pulisher
Oct 27, 2025

I-Mab stock reaffirmed as Buy at H.C. Wainwright on positive cancer drug data - Investing.com

Oct 27, 2025
pulisher
Oct 24, 2025

I-Mab Rebrands to NovaBridge Biosciences Following Shareholder Approval - TipRanks

Oct 24, 2025
pulisher
Oct 17, 2025

I-Mab stock price target raised to $9 from $7 at BTIG on strategic shift - Investing.com

Oct 17, 2025
pulisher
Oct 16, 2025

I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO By Investing.com - Investing.com South Africa

Oct 16, 2025
pulisher
Oct 16, 2025

I-Mab to rebrand as NovaBridge Biosciences, plans Hong Kong IPO - Investing.com

Oct 16, 2025
pulisher
Oct 08, 2025

Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday - Benzinga

Oct 08, 2025
pulisher
Oct 03, 2025

This Bank of New York Mellon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga

Oct 03, 2025
pulisher
Sep 30, 2025

Why Wolfspeed Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 30, 2025
pulisher
Sep 04, 2025

C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAcadian Asset Management (NYSE:AAMI), C3.ai (NYSE:AI) - Benzinga

Sep 04, 2025
pulisher
Aug 15, 2025

Evolv Technologies, Precigen, Hesai Group And Other Big Stocks Moving Higher On Friday - Benzinga

Aug 15, 2025
pulisher
Aug 14, 2025

Kimball Electronics Posts Better-Than-Expected Earnings, Joins Terawulf, Dlocal, Equinox Gold And Other Big Stocks Moving Higher On Thursday - Benzinga

Aug 14, 2025
pulisher
Jan 03, 2023

Morningstar’s Best- and Worst-Performing Stocks: 2022 - Morningstar

Jan 03, 2023
pulisher
Dec 19, 2022

10 of the Cheapest Stocks of 2022 - Morningstar

Dec 19, 2022
pulisher
Oct 03, 2022

The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar

Oct 03, 2022
pulisher
May 20, 2022

New 5-Star Stocks - Morningstar

May 20, 2022
pulisher
Apr 11, 2020

ORIC Stock Price | Oric Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) - MarketWatch

Apr 11, 2020
pulisher
Nov 15, 2016

ADPT Stock Price | Adaptive Biotechnologies Corp. Stock Quote (U.S.: Nasdaq) - MarketWatch

Nov 15, 2016

Novabridge Biosciences Adr (NBP) 財務データ

Novabridge Biosciences Adr (NBP) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.54
price down icon 0.53%
$31.40
price up icon 1.88%
$105.55
price down icon 0.65%
$99.71
price up icon 3.28%
biotechnology ONC
$335.17
price up icon 0.74%
$209.02
price up icon 1.01%
大文字化:     |  ボリューム (24 時間):